DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators.
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.
Lancet 2001;
358 (9282) 605-613
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.